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ty) as compared to PD without AG and AG without PA. 
 Conclusions: Differences in incidence patterns, syndrome 
progression and outcome, and syndrome stability over time 
indicate that AG exists as a clinically significant phobic condi-
tion independent of PD. The majority of agoraphobic sub-
jects in this community sample never experienced PA, calling 
into question the current pathogenic assumptions underly-
ing the classification of AG as merely a consequence of panic. 
The findings point to the necessity of rethinking diagnostic 
concepts and DSM diagnostic hierarchies.  
Copyright © 2008 S. Karger AG, Basel
 
 Background 
 The question of whether agoraphobia (AG) constitutes 
a separate, independent diagnostic category distinct from 
panic attacks (PA) and panic disorder (PD) is a matter of 
contention  [1–10] . DSM-IV hierarchy rules result in the 
nearly unconditional priority of PA and PD over the di-
agnosis of AG. That is, AG is not a codable disorder but 
is rather diagnosed only in the context of PD (i.e., PD 
with AG) or as the result of PA or panic-like features (i.e., 
AG without a history of PD). The subordinate status of 
AG is inconsistent with epidemiological studies, which 
have repeatedly observed a substantial portion of AG cas-
es that occur independently of PA  [4, 11–21] with similar 
degrees of associated impairments  [22, 23] .
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 Abstract 
 Background: The relationship of panic attacks (PA), panic 
disorder (PD) and agoraphobia (AG) is controversial. The aim 
of the current study is to prospectively examine the 10-year 
natural course of PA, PD and AG in the first three decades of 
life, their stability and their reciprocal transitions.  Methods: 
DSM-IV syndromes were assessed via Composite Internation-
al Diagnostic Interview – Munich version in a 10-year pro-
spective-longitudinal community study of 3,021 subjects 
aged 14–24 years at baseline.  Results: (1) Incidence patterns 
for PA (9.4%), PD (with and without AG: 3.4%) and AG (5.3%) 
revealed differences in age of onset, incidence risk and gen-
der differentiation. (2) Temporally primary PA and PD re-
vealed only a moderately increased risk for subsequent onset 
of AG, and primary AG had an even lower risk for subsequent 
PA and PD. (3) In strictly prospective analyses, all baseline 
groups (PA, PD, AG) had low remission rates (0–23%). Baseline 
PD with AG or AG with PA were more likely to have follow-up 
AG, PA and other anxiety disorders and more frequent com-
plications (impairment, disability, help-seeking, comorbidi-
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 The residual status of AG in the DSM-IV emphasizes 
one etiological pathway to the exclusion of others. The 
DSM perspective links spontaneous PA and its assumed 
neurobiological and neuropsychological role to subse-
quent AG. In contrast, independent conceptualizations 
of AG do not view PA as a necessary etiological precursor, 
though it is one possible pathway to AG in clinical popu-
lations  [9, 24–30] . These distinctions have clear implica-
tions for nosological issues and can also affect treatment. 
For instance, current hierarchical rules might result in 
underrecognition and undertreatment of AG. Further, 
the DSM perspective suggests targeting primarily panic-
related symptoms and the associated catastrophic cogni-
tions. In contrast, AG patients who have never had panic-
like symptoms may more closely resemble subjects with 
specific phobia and therapy may require predominantly 
targeting agoraphobic avoidance by situational exposure 
 [31–33] .
 In order to investigate the independence of AG and 
PA/PD, we collected prospective longitudinal data dur-
ing high-risk periods for psychopathological develop-
ment (i.e., adolescence and young adulthood). Further-
more, we measured these constructs using assessment 
algorithms that allowed for nonhierarchical responses, 
lest they could only substantiate the diagnoses from 
which the definitions were derived. In our previous study 
 [4, 34] , we found evidence for the existence of a fairly 
large, clinically impaired group of AG that occurred not 
only outside the context of PD but without any notable 
signs of PA or panic-like symptoms. That study was note-
worthy because all AG cases were verified by indepen-
dent clinical reviewers based on strict definitions. The 
results suggested that various etiological pathways lead to 
AG, some with and some without panic symptoms. As a 
follow-up, the current study continues this exploration by 
examining the 10-year natural course, incidence and pro-
spective temporal patterns of symptoms and associated 
impairments of PA, PD and AG with and without the use 
of hierarchical rules. Thus, the current study tests the 
longitudinal stability and validity of our previous find-
ings. Overall, the goal of the current study was to further 
examine the diagnostic independence of AG and the role 
of PA and PD in its etiology. To this end, we (1) describe 
patterns of incidence of PA, AG and PD; (2) investigate 
the natural course and reciprocal transitions of these syn-
dromes with each other, and (3) examine the degree to 
which the syndromes differ on selected clinical corre-
lates.
 Methods 
 Subjects and Setting 
 Data were collected under the auspices of the Early Develop-
mental Stages of Psychopathology Study, a prospective cohort 
study of the prevalence, incidence, familial and other risk factors, 
comorbidity and course of mental disorders in a representative 
sample of adolescents and young adults in Munich, Germany. The 
study consisted of a baseline survey, three follow-up surveys and 
two family supplements (not dealt with in this paper). The base-
line sample was drawn randomly from the 1994 government reg-
istry of all residents aged 14–24 years in greater metropolitan Mu-
nich. Consistent with the aim of studying the onset of mental 
disorders, respondents aged 14–15 years were sampled at four 
times the probability of 22- to 24-year-olds, and respondents aged 
16–21 years were sampled at twice the probability of 22- to 24-
year-olds  [35–37] .
 The results reported in this article are based on 3,021 respon-
dents, except for prospective analyses in the subset of indepen-
dently validated cases with baseline diagnoses of PA, PD and 
AG.
 Diagnostic Assessment 
 The standardized diagnostic assessment interview Composite 
International Diagnostic Interview – Munich version (DIA-X/
M-CIDI)  [38] was used to evaluate symptoms, syndromes and 
diagnoses according to DSM-IV and ICD-10 criteria. Psychomet-
ric properties of the Composite International Diagnostic Inter-
view have been established in several studies, with excellent re-
sults for PA, PD and AG  [39–41] .
 Measures of Panic and Agoraphobia 
 Assessment of PD began with the question: ‘Have you ever had 
an attack when all of a sudden you felt frightened, anxious or very 
uneasy?’ When endorsed, the respondents were asked whether at 
least one attack occurred ‘out of the blue’ and to provide examples 
that were recorded verbatim. Twenty-one questions about the 
DSM-IV criteria for PA and PD followed. In addition, the patients 
were queried about their help-seeking behaviors, results of medi-
cal evaluations, as well as the age of onset, frequency and context 
of the attacks (i.e. situationally predisposed or situationally bound 
agoraphobic and social situations). No skips were used in the as-
sessment of PA, thus allowing for the evaluation of various sub-
threshold manifestations, such as fearful spells (FS).
 All participants were assessed for AG, irrespective of their an-
swers to the panic sections. The AG stem question assed six man-
datory situations: ‘Have you ever had a strong fear of or did you 
avoid (a) leaving your home or being outside your home, (b) trav-
eling in a bus, train or car, (c) being in a crowd or standing in a 
line, (d) being in a public place, like a shop, (e) going on a long 
journey, (f) crossing a bridge?’ If at least one situation was en-
dorsed, the respondents were asked to give examples of what was 
feared in these situations. As in the panic section, answers were 
recorded verbatim. Subsequently, DSM-IV criteria were probed 
(e.g., frequency/degree of avoidance, distress or impairment, etc.). 
It is important to note that, so assessed, the focus of AG is on the 
feared situations themselves and not, as stated in the DSM-IV 
definition of AG without history of PD, ‘on the occurrence of in-
capacitating or extremely embarrassing panic-like symptoms or 
limited-symptom attacks’ [ 42 , p. 403]. Verbatim responses along 
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with treatment information were clinically validated via case re-
views by three independent US clinical psychologists and psy-
chiatrists highly experienced in anxiety and clinical interviews. 
This processes yielded unanimous agreement on all cases of AG 
with at least two trigger situations as ‘true’ cases of AG   [4] . Defini-
tions of panic and AG are consistent with those used in our previ-
ous analyses, including the convention of diagnosing AG only 
when two or more agoraphobic trigger situations were present.
 Diagnostic Comparison Groups 
 The results in the present paper are based on two different 
groups of participants. First, the total sample (n = 3,021) was used 
to investigate cumulative incidence patterns and associations. We 
examined PA, PD and AG with and without the use of DSM-IV 
hierarchical rules. As shown in  figure 1 (bold), use of hierarchy 
rules examined across all assessment waves resulted in 54 PD with 
AG, 47 PD without AG (PD total: n = 101) and 21 AG without the 
history of PD. Without hierarchy rules, 283 met criteria for DSM-
IV PA, 154 for AG and 101 for PD. It should be noted that among 
the 154 cases with AG, 45 revealed no history of either PA or any 
panic-like experiences.
 Second, only independently verified baseline cases  [4] were 
used for prospective analyses. This strategy provided a stricter 
test of transitions in terms of conditional probabilities and elimi-
nated the possibility of misdiagnosis. This subset (total baseline 
n = 180) consists of 20 cases with PD with AG, 22 PD without AG 
and 69 cases of AG without a history of PD when using diagnostic 
hierarchies; 69 had PA only at baseline. Without DSM-IV hierar-
chical rules 122 PA cases, 42 PD cases and 89 AG cases were iden-
tified. Due to follow-up attrition, the number of eligible cases for 
the strict prospective analysis was slightly reduced, leaving 108 
PA, 38 PD and 80 AG cases.
 Clinical Characteristics and Comorbid Disorders 
 Age of onset was defined as  the lowest age of onset reported at 
baseline or at follow-up. Social role impairment was based on im-
pairment in various social roles caused by the fear of situations or 
agoraphobic avoidance in the four weeks prior to the interview. 
Disability was defined as the mean number of disability days due 
to mental problems across all available interviews. Finally, help-
seeking was defined as having contacted a medical doctor or an-
other health professional about problems due to panic or agora-
phobic symptoms.
 Data Analysis 
 Baseline prevalence covers the respondents’ life up to the base-
line assessment. The complete follow-up status is based on the ag-
gregated information through follow-up. Cumulative incidence 
was calculated by aggregating baseline, first, second and third fol-
low-up information. In the case of nonresponses, last observation 
carried forward methodology was used. Data are weighted by sex, 
age and geographic location at baseline to match the distribution 
of the sampling frame  [36] . The ‘robust sandwich method’ was 
used for statistical inference with weighted data  [43] . Differences 
in binary outcomes were assessed with odds ratios (ORs) from lo-
gistic regressions. The number of available observations varied 
slightly between analyses due to missing information. For all anal-
yses the statistical significance was set at the 5% level (p  ! 0.05, 
2-tailed).
 Curves were fit according to gender and baseline age (‘strati-
fied Cox regression’). To account for large confidence intervals 
(CI) with limited interpretability, all survival curves are present-
ed only if at least 20 subjects were under risk. Otherwise the curve 
was cut at the respective age. Additionally, we assessed differ-
ences with regard to age cohort (14–17 years vs. 18–24 years at 
baseline), gender and the interaction of both on the longitudinal 
incidence using hazard ratios (HRs) from Cox regression. We fit 
the Cox regressions stratified for sex and age cohort if both vari-
ables were not of primary interest. The model fit  was assessed with 
Schönfeld residuals  [44] . A violation of the assumptions would 
indicate that the respective effect was not constant over the entire 
age period. The main effect of cohort as well as the interactions 
for cohort and gender on the longitudinal incidence can only be 
estimated in the life period that all respondents had passed equal-
ly, that is up to the age of 21 (as the youngest participants were 21 
years at the final assessment). We also assessed whether the mean 
age of onset differed by gender if the respondent developed the 
outcome. Therefore we added the interaction term gender  ! time 
to the model. The age-dependent HR in such a model is given by 
the term HR (main effect)  ! HR (interaction) age . Finally, we as-
sessed whether the risk for PA, PD or AG (outcome) was higher in 
cases where another syndrome (condition) X preceded the onset 
of the outcome using age of onset information on X. Therefore we 
computed the main effect of the age-dependent variable X(t) ‘con-
dition before outcome’, where X(t) equals 1 if X occurs before age 
t – 1 and equals 0 otherwise. Therefore we computed the main ef-
fect of the age-dependent variable ‘condition before outcome’. 
This implies that the condition predates the outcome by at least 
one year.
FS (n = 792; 25.6%)
PA (n = 283; 9.4%)
PD (n = 101; 3.4%)
AG (n = 154; 5.3%)
45
(1.5%)
AGwithout FS
34
(1.3%)
AGwith FS only
21 (0.6%)
54
(1.9%)
47
(1.5%)
PD with AG
PD without AG
AG without the history of PD
 Fig. 1. Cumulative lifetime incidence (up to the age of 34) of fear-
ful spell (FS), DSM-IV PA, DSM-IV PD and DSM-IV AG (n = 
3,021). Bold labels represent DSM-IV diagnoses; italic labels are 
terms which do not appear in the DSM-IV; hierarchical diagnos-
tic groups are in the lower half of the figure and nonhierarchical 
ones in the upper half. 
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 Results 
 Incidence Patterns of Panic and Agoraphobia 
 Figure 1 presents the number of individuals and the cu-
mulated incidences of PA (9.4%), PD (3.4%) and AG (5.3%) 
and their overlap in the total sample. Using strict DSM-IV 
diagnostic criteria, the rates for PD without AG were 1.5%, 
1.9% for PD with AG and 0.6% for AG without the history 
of PD. The difference between hierarchical (bold) and 
nonhierarchical definitions resulted in a majority [(34 + 
45)/154 = 51.3%] of agoraphobic cases who would go for-
mally undiagnosed within the panic-AG spectrum. These 
individuals without a diagnosis result because they did not 
experience PA as required in DSM-IV-TR (i.e., AG with FS 
only = 1.3% and AG without FS = 1.5%). It is especially sa-
lient that more than half of those did not even experience 
extremely broadly defined panic-like symptoms (i.e., AG 
without FS; 45/79 = 57.0%) and represent nearly a third of 
all agoraphobic subjects (45/154 = 29.2%).
 As evidenced by  figure 2 , PA, PD and AG develop in 
considerably diverse ways. Onset of PA before the age of 
13 was rare (estimated median: females = 21.5 years, males 
= 20 years), and gender differences were not apparent be-
fore the age of 15. Further, the data suggest a leveling off 
of incidence for women at the age of 26 1 . Similar to PA, 
 1  The indication for a second peak appearing after the age of 30 should 
be regarded with caution because of the low number of observations. 
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 Fig. 2. Cumulative incidence by gender of  PA ( a ), PD ( b ), AG ( c ) and FS ( d ) with and without panic symptoms 
up to the third follow-up (n = 3,021). Estimated median was calculated by dividing the cumulated probability 
at age 34 years by two and identifying the corresponding age at which that incidence was achieved. 
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the incidence for PD reveals a very clear-cut period of in-
creased incidence in women between the ages of 13 and 
26, with no new onsets of PD after this age. Males dis-
played considerably lower estimates and the period of in-
creased incidence is less pronounced. However, similar to 
women there were no new onsets after the age of 25. It 
should be noted that unlike PA, the gender difference is 
apparent in cases before the age of 14 but widens consid-
erably further between the ages of 14 and 25. In contrast 
to PA and PD, AG unanimously reveals a strong and 
steady incidence increase for females after the age of 6 (es-
timated median: 19). AG in males was observed consider-
ably less frequently, with some indication of increased in-
cidence between the ages of 15 and 20 and a leveling off 
after the age of 25 (estimated median: 17.5). The onset of 
FS can occur at any point after the age of 5 in both sexes 
(estimated median: females = 19, males = 19.5), with in-
creasing gender differences emerging after the age of 12.
 All syndromes showed a higher risk for women with 
no indication that women had a significantly earlier on-
set than men. The gender-specific hazards ranged from 
1.7 (FS) to 2.7 (PD). Further, no significant risk difference 
emerged between the younger and older birth cohort (14- 
to 17-year-olds vs. 18- to 24-year-olds at baseline) or be-
tween different combinations of gender and age cohort 
for any condition.
 Transitions: Risk of PA, PD and AG by Preceding 
Diagnostic Status 
 In this section we examined the implicit DSM-IV as-
sumption that AG results from primary PA. Specifically, 
we investigated how frequently temporally primary PA or 
PD were associated with subsequent AG. Further, we ex-
amined how frequently temporally primary AG with and 
without PA were associated with subsequent PA or PD. 
For these analyses, the full data set and age of onset in-
formation for each condition was used for temporal or-
dering. Reference groups for these analyses consisted of 
the individuals who developed the outcome disorder but 
did not previously have the reference disorder (see  ta-
ble 1 ).
 Consistent with the definition of PD, PA preceded PD 
in all observed outcomes. Nearly a quarter (23.5%) of the 
subjects who had a PA developed subsequent AG and 
slightly more than half of the cases with PD developed 
subsequent AG (54.9%). Likewise, the overall hazard ra-
tios for these two temporal patterns were highly pro-
nounced with CI suggesting at least a 17-fold risk to de-
velop AG after onset of PA and at least a 38-fold risk to 
develop AG after onset of PD as compared to subjects 
without PA. Moreover, as indicted by the interaction 
terms with age, the hazard ratio of PA decreases signifi-
cantly with increasing age, indicating that the prior con-
Table 1. Temporally directed association between PA, PD and AG (total data set, n = 3,021, without diagnostic hierarchies)
Temporal pattern
(primary to
subsequent condition)
Total Eligible
number at
risk
Observed num-
ber of outcomes
Overall
associations
Model including interaction with age
n %w HR 95% CI HR (main
effect)
95% CI HR (inter-
action effect)1
95% CI
PA to PD 283 277 100 37.0 – – – – – –
No PA to PD 2,738 2,738 0 0.0
PA to AG 283 264 60 23.5 26.7 17.2–41.7 124.5 40.9–378.7 0.9 0.85–0.97
No PA to AG 2,738 2,732 87 3.1
PD to AG 101 98 51 54.9 62.5 38.5–101.2 228.6 62.7–833.0 0.9 0.86–1.1
No PD to AG 2,920 2,914 96 3.3
AG to PA 154 135 13 11.6 1.8 0.9–3.5
No AG to PA 2,867 2,863 264 8.8
AG to PD 154 92 2 2.4 1.0 0.2–4.9
No AG to PD 2,867 2,867 98 3.3
Eligible number at risk: number at risk – number of eligible subjects at risk for temporally secondary disorder during follow-up. 
Numbers differ because of varying numbers of subjects who either developed the outcome preceding the condition or had no age of 
onset information. %w = Weighted percent; HR = hazard ratio, reference group is the group without preceding syndrome.
1 Age-dependent HR = HR (main effect) ! HR (interaction effect)age.
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dition is also related to an accelerated onset of the out-
come. This might possibly be due to a significant interac-
tion with age, suggesting that the lower the age of onset 
of PA, the greater the risk of developing subsequent 
AG – at least when compared to individuals who devel-
oped AG without previous PA. Taken together, these 
findings suggest that the occurrence of PA and PD sig-
nificantly increases the odds of developing AG. It should 
be noted, however, that odds determined from the hazard 
ratios are calculated in reference to the individuals who 
never had PA or PD and developed AG. Furthermore, 
45.1% of the individuals at risk with PD and 76.5% of 
those at risk with PA did not develop AG. Subjects with 
AG did not have significantly increased odds of develop-
ing a subsequent PA or PD. This is also evidenced by the 
fact that only 11.6% of those with AG developed a subse-
quent PA and only 2.4% developed a subsequent PD.
 Strict Prospective Analysis of Diagnostic Stability and 
Transitions 
 The previous analyses using the total data set (n = 
3,021) were repeated with the subset of independently 
validated cases in a strictly prospective-longitudinal 
manner. Although this is associated with some loss of 
statistical power due to attrition and lower base rates, it 
provides a more stringent examination of diagnostic sta-
bility and transitions by limiting the effects of recall bias. 
Additionally, this approach has the advantage of examin-
ing not only the question of transition but also the issues 
of remission and stability. These analyses used hierarchi-
cally defined, verified baseline cases of PA, PD and AG to 
prospectively examine the further course over the follow-
up period. The follow-up occurrence of PA, PD, AG and 
other anxiety disorders in the follow-up period was de-
termined without the use of diagnostic hierarchies. For 
each comparison ORs were estimated with a reference 
group of subjects with neither diagnostic condition. Base-
line cases were classified as remitted when neither PA nor 
any other DSM-IV disorder was observed in the follow-
up period.
 As shown in  table 2 , baseline PA and PD cases did not 
have a significantly increased risk for subsequent AG (PA: 
3.3%, OR: 1.4, 95% CI: 0.3–7.2; PD: 10.0%, OR: 4.1, 95% 
CI: 0.9–19.5) as compared to the reference group with nei-
ther PA nor AG. In contrast, all diagnostic groups with 
baseline AG (i.e., AG without PA, AG with PA and PD 
with AG) had elevated risks for subsequent AG during the 
follow-up period. Examination of the follow-up status of 
PA/PD revealed a different pattern. All baseline diagnos-
tic groups except for AG without PA clearly increased the 
odds of subsequent PA/PD. The increased odds for sub-
sequent PA/PD given baseline AG without PA were not 
statistically significant and much weaker than other 
baseline groups. It should be further noted that all base-
line diagnostic groups except for PD without AG had de-
creased odds of follow-up remission (i.e., no disorder), 
suggesting that these baseline conditions are risk factors 
for subsequent psychopathology.
 Selected Clinical Correlates of Panic and Agoraphobia 
 We also examined whether PD with and without AG 
and AG without the history of PD differed from the AG 
Table 2. Risk (percent, OR) of baseline diagnostic groups (mutually exclusive) for being diagnosed as having AG, PA/PD, other anxi-
ety disorders or any diagnosis during the follow-up period (not mutually exclusive)
Baseline status 
(mutually exclusive 
diagnostic groups)
Baseline prevalence Follow-up status (at first, second or third follow-up assessment)
AG PA/PD
n %w Ne %w %w
no
%w
yes
OR 95% CI %w
no
%w
yes
OR 95% CI
No PA/no AG (ref.) 2,840 93.6 2,635 94.3 97.7 2.3 1.0 – 94.5 5.5 1.0 –
PA/no AG 69 2.4 61 2.2 96.7 3.3 1.4 0.3–7.2 71.2 28.8 6.8 3.5–13.2
AG without PA 58 2.0 53 1.9 81.8 18.3 8.3 3.5–19.3 88.4 11.7 1.9 0.8–4.3
AG with PA 11 0.3 9 0.3 67.5 32.5 20.6 4.8–9.4 40.7 59.4 21.3 5.5–83.3
PD without AG 22 0.8 20 0.7 90.0 10.0 4.1 0.9–19.5 58.2 41.8 10.7 4.0–28.7
PD with AG 20 0.8 18 0.6  44.9 55.1 45.1 16.4–124.0  27.6 72.5 38.7 13.7–109.1  
Follow-up status: follow-up groups are not mutually exclusive. No DSM-IV diagnosis: no PA, PD, AG, other anxiety disorder, mood dis-
orders, somatoform disorders, eating disorders, alcohol dependence and illicit substance dependence. n = Unweighted number; Ne = eligible 
number (at least one follow-up assessment available); %w = weighted percentage; OR = odds ratio from logistic regression; adjusted for sex 
and age at last assessment; n.d. = OR not defined due to empty cells.
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
ts
bi
bl
io
th
ek
 M
ed
izi
n 
Ba
se
l  
   
   
   
   
   
  
13
1.
15
2.
21
1.
61
 - 
10
/2
5/
20
17
 7
:5
7:
02
 A
M
 PDAG in the First Three Decades Psychother Psychosom 2008;77:147–157 153
cases without any signs of PA or panic-like symptoms. 
Almost all comparisons were significantly different from 
the reference group of subjects without PA, AG or PD 
(data available on request). Further, AG with PA vs. AG 
without PA showed more work impairment, while AG 
with PA vs. PD without AG and PD with AG vs. PD with-
out AG showed more leisure impairment. Regarding help-
seeking, expected patterns emerged: participants with PD 
without AG were more likely to consult a medical doctor 
due to panic and less likely to do so for AG as compared 
to participants with AG (with or without PA). Help-seek-
ing for both panic and AG was most pronounced in par-
ticipants with co-occurring syndromes (PD with AG). 
Overall, participants with AG without PA were less likely 
to contact any health professional as compared to all oth-
er diagnostic groups. PD with AG was associated with the 
highest overall help-seeking rate, which was significantly 
greater than for individuals with PD without AG.
 Discussion 
 The purpose of this study was to describe the relation-
ship of AG with PA and PD by prospectively examining 
the natural course and development of each condition in 
the first three decades of life. Overall our findings indi-
cated that AG is a clinically significant disorder that exists 
independently of PA and PD in a substantial number of 
cases. We came to this conclusion based on (a) different 
patterns of incidence and gender differentiation between 
PA, AG and PD, (b) differences in the temporal progres-
sion and syndrome stability of AG with and without PA as 
well as PD with and without AG, (c) a lack of consistency 
regarding the role of temporally primary PA as the core 
pathogenic mechanism of onset for AG, as assumed in the 
DSM-IV, (d) patterns in salient clinical correlates and out-
comes, and (e) the demonstration that even in AG cases 
without any indications of panic-like features similar im-
pairment and outcomes were observed as those with PA. 
These findings do not call into question either the detri-
mental effects of PA or that there is a close, potentially 
casual link between initial PA and the onset of PD and AG 
in some cases. However, this association only accounts for 
about 50% of all agoraphobic subjects in this sample. 
These findings argue that AG should exist as a separate 
diagnostic category independent of PA and PD and sug-
gest the elimination of the diagnostic hierarchy rules of 
DSM. Furthermore, the results provide evidence for the 
existence of various pathogenic pathways leading to AG.
 With respect to incidence, the cumulative incidence of 
the DSM-IV categories PD with AG (1.5%), PD without 
AG (1.9%) and AG without history of PD (0.6%) up to the 
age of 34 all lie within the range of reports in other gen-
eral population studies  [13, 14, 17–19, 22, 34, 45–57] . 
However, disregarding the DSM-IV hierarchy rules, we 
longitudinally confirmed previous findings that the inci-
dences of DSM-IV PA (9.4%) and AG (5.3%) occur much 
more frequently than the rates of the above diagnoses to-
gether. Thus, consistent with previous cross-sectional 
findings, the occurrence of PA does not result in the onset 
of PD or AG in a large proportion of cases  [58, 59] .
other anxiety disorders no DSM-IV diagnosis
%w
no
%w
yes
OR 95% CI %w
no
%w
yes
OR 95% CI
80.6 19.4 1.0 – 48.9 51.1 1.0 –
62.6 37.4 2.4 1.4–4.3 79.8 20.2 0.2 0.1–0.5
53.2 46.8 2.9 1.5–5.5 79.7 20.3 0.3 0.1–0.6
0.0 100.0 n.d. 100.0 0.0 n.d.
65.1 34.9 1.8 0.7–5.0 76.9 23.1 0.3 0.1–1.1
31.5 68.5 7.4 2.5–21.6 91.9 8.1 0.1 0.0–0.7
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 Considerations of the temporal progression and sta-
bility of syndromes point to diverse developmental path-
ways of PA, PD and AG. For instance, the observed mean 
and median age of onset was lower in AG than PA or PD. 
Further, although women’s risk of developing one of these 
syndromes was elevated for each of the disorders, gender 
differences with respect to patterns of development were 
most profound for AG.
 The results did not support the DSM-IV assumption 
that primary PA are predominantly associated with in-
creased risks to develop AG. These findings were consis-
tent in both the overall sample and in the more detailed 
strictly prospective examination. Instead, temporally 
primary PA or PD was found to be associated either mod-
erately or not at all with subsequent AG. The findings are 
also inconsistent with claims that AG outside the panic 
spectrum is clinically irrelevant. The results revealed that 
only 20% remit and that these cases reveal a similar pat-
tern of impairment and comorbidity. The relationship 
does not appear to be reciprocal, especially in cases of AG 
without PA. Thus, the noncomorbid manifestation of AG 
demonstrates different temporal patterns than PA and 
PD and appears to be qualitatively different.
 Taken together, these results call into question the 
view that AG is the mere consequence or complication of 
PA and PD, as suggested in the prominent symptom pro-
gression model  [26, 60] , and may suggest (a) that this 
model applies only to a subgroup of patients  [4, 11–19] , 
(b) that neither the occurrence nor the anticipation of 
spontaneous panic is predictive of agoraphobic severity 
 [61] , (c) that AG and PD have at least some distinct ge-
netic risk factors  [62] , and (d) that residual symptoms of 
AG are a risk factor for relapse of panic in treated patients 
 [63] . Alternative pathogenic mechanisms leading to AG 
are presently not as clear as those leading from AG to the 
relatively few cases with temporally secondary panic. 
Consistent with the speculation of Fava and Mangelli 
 [63] , we believe that the causal chain is dependent upon 
multiple pathways and multiple factors. One immediate 
and direct interpretation is that AG is an independent 
phobic disorder in its own right, like social phobia or spe-
cific phobias. Although this study examined AG at the 
level of validated syndromes  [4] , previous studies suggest 
that an evaluation at the subclinical symptom level would 
actually increase the number of patients for whom PA/
PD is preceded by AG symptoms  [63] . However, future 
studies are needed to further examine these issues in 
greater detail.
 In terms of impairment, disability, help-seeking and 
comorbidity, all diagnostic groups revealed substantial 
complications even after accounting for the presence of 
comorbid conditions. Cases with comorbid PD and AG 
tended to have the least favorable clinical correlates. It is 
noteworthy that AG without PA was significantly less 
likely to seek help than all other diagnostic groups despite 
having a similar range of impairments. This supports the 
hypothesis of Weissman et al.  [64] that a unidirectional 
relationship from PA to AG was valid for patients seeking 
help for panic symptoms, whereas patients with only AG 
remain at home and fail to seek treatment. If true, one 
might conclude that individuals with AG but without 
panic symptoms are not incapacitated enough to seek 
help  [4, 65] and thus panic patients with AG in former 
studies represented a help-seeking subtype.
 This study had several strengths. First, developmental 
patterns of panic and AG were examined using a pro-
spective 10-year longitudinal design with assessments 
close to the age of onset in a large community sample. 
Second, we analyzed the onset and incidence patterns of 
PA, PD and AG using a standardized diagnostic inter-
view that allowed for nonhierarchical responses. This al-
lowed us to investigate these conditions with and with-
out the current DSM hierarchical rules and to extend 
previous studies by examining onsets conditional on one 
another. Third, the impact of recall bias and of potential 
diagnostic imprecision was further minimized by pro-
spectively examining a subset of independently verified 
cases of AG established in a previous publication. These 
occurred in addition to overall analyses in the full data 
set. Finally, it should also be highlighted that our study 
provided a fuller incidence description than previous 
studies, most of which were cross-sectional and/or re-
stricted to clinical samples.
 The results of this study must be interpreted in light 
of several limitations. First, the age of onset analyses re-
vealed that the high-risk period for the syndromes had 
not ended at the final follow-up of our fairly young re-
spondents. Thus, a number of subjects in our sample 
might therefore still be at risk. As a result, our data can 
only apply to the first three decades of life and not be-
yond. Second, we observed selective attrition from base-
line to follow-up for respondents with substance use dis-
orders, including nicotine dependence. If cigarette smok-
ing is a risk factor for PA  [66, 67] , the selective dropout 
may have led to an underestimation of PA and PD and 
consequently to an underestimation of cases with panic 
and AG. However, we did not find selective attrition for 
PA or AG. Third, the childhood age of onset retrospec-
tively assessed at baseline is subject to memory bias. 
However, we are not aware of a memory bias that is spe-
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cific to only one of the syndromes and therefore it should 
not have an impact on the temporal relationship of pan-
ic and agoraphobic symptoms. Finally, this sample had a 
relatively low number of PD cases who, despite signifi-
cant associations with impairment and help-seeking, 
may represent a less severe subgroup of PD relative to 
patients in clinical studies.
 With these limitations in mind, we conclude that the 
differences in incidence patterns, the further progression 
and outcome, the syndrome stability over time and the 
existence of multiple reciprocal relationships between 
PA, AG and PD strongly suggest that AG exists as a clin-
ically significant phobic condition independent of PD. 
The majority of agoraphobic subjects in this community 
sample have never experienced PA. This calls into ques-
tion the current pathogenic assumptions underlying the 
present classification of AG as being merely a conse-
quence of panic. The findings are more consistent with 
the assumption of various pathogenic pathways and sug-
gest a need for rethinking diagnostic concepts and chang-
es in the DSM classification and diagnostic algorithms.
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